CD4 and breast carcinoma: Previous studies on TILs in breast cancer identified lymphocyte populations that were mainly comprised of CD8+ cytotoxic T cells and CD4+ regulatory cells together with varying proportion of other helper T cells, B cells and NK cells [26].